Engineering of bacterial strains and vectors for the production of plasmid DNA

Applied Microbiology and Biotechnology

Volumn 82, Issue 5, 2009, Pages 805-813

  Bower, Diana M ^a   Prather, Kristala L J ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

DNA vaccines; Escherichia coli; Gene therapy; Plasmid DNA; Strain engineering

Indexed keywords

BACTERIAL STRAINS; BIOPHARMACEUTICALS; CLINICAL TRIALS; DNA VACCINES; GENE THERAPY; HOST STRAINS; MANUFACTURING PROCESS; NON-TRADITIONAL; NON-VIRAL GENE THERAPIES; PLASMID DNA; PLASMID DNA (PDNA); PLASMID STABILITIES; PRODUCT SAFETIES; STRAIN ENGINEERING;

BACTERIOLOGY; DNA; ENGINEERING RESEARCH; ESCHERICHIA COLI; GENES; GENETIC ENGINEERING; INDUSTRIAL RESEARCH; INNOVATION; STRAIN; VACCINES; VECTORS;

NUCLEIC ACIDS;

BACTERIUM; DNA; GENETIC ENGINEERING; PLASMID; VACCINE;

ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; GENOMIC INSTABILITY; HUMANS; IMMUNOTHERAPY, ACTIVE; INDUSTRIAL MICROBIOLOGY; PLASMIDS; SAFETY; VACCINES, DNA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 62949222607     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-009-1889-8     Document Type: Short Survey

References (56)

1. X Bi LF Liu 1996 A replicational model for DNA recombination between direct repeats J Mol Biol 256 849 858
2. AC Boyd F Popp U Michaelis H Davidson H Davidson-Smith A Doherty G McLachlan DJ Porteous S Seeber 1999 Insertion of natural intron 6a-6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination J Gene Med 1 312 321
3. Butler VA (1996) Points to consider on plasmid DNA vaccines for preventive infectious disease indications. Center for Biologics Evaluation and Research, Food and Drug Administration. Docket 96N-0400
4. AE Carnes CP Hodgson JA Williams 2006 Inducible Escherichia coli fermentation for increased plasmid DNA production Biotechnol Appl Biochem 45 155 166
5. JH Chen HT Yeh 1997 The seventh copy of IS1 in Escherichia coli W3110 belongs to the IS1 A (IS1E) type which is the only IS1 type that transposes from chromosome to plasmids Proc Natl Sci Counc Repub China B 21 100 105
6. ZY Chen CY He MA Kay 2005 Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo Hum Gene Ther 16 126 131
7. LAS Ciccolini PA Shamlou NJ Titchener-Hooker JM Ward P Dunnill 1998 Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release Biotechnol Bioeng 60 768 770
8. GD Cooke RM Cranenburgh JAJ Hanak P Dunnill DR Thatcher JM Ward 2001 Purification of essentially RNA free plasmid DNA using a modified Escherichia coli host strain expressing ribonuclease A J Biotechnol 85 297 304
9. RM Cranenburgh JA Hanak SG Williams DJ Sherratt 2001 Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration Nucleic Acids Res 29 E26
10. RM Cranenburgh KS Lewis JA Hanak 2004 Effect of plasmid copy number and lac operator sequence on antibiotic-free plasmid selection by operator-repressor titration in Escherichia coli J Mol Microbiol Biotechnol 7 197 203
11. MK Danquah GM Forde 2007 Growth medium selection and its economic impact on plasmid DNA production J Biosci Bioeng 104 490 497
12. AM Darquet B Cameron P Wils D Scherman J Crouzet 1997 A new DNA vehicle for nonviral gene delivery: supercoiled minicircle Gene Ther 4 1341 1349
13. R Dryselius N Nekhotiaeva PE Nielsen L Good 2003 Antibiotic-free bacterial strain selection using antisense peptide nucleic acid BioTechniques 35 1060 1064
14. T Durfee R Nelson S Baldwin G Plunkett III V Burland B Mau JF Petrosino X Qin DM Muzny M Ayele RA Gibbs B Csorgo G Posfai GM Weinstock FR Blattner 2008 The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse J Bacteriol 190 2597 2606
15. GNM Ferreira GA Monteiro DMF Prazeres JMS Cabral 2000 Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications Trends Biotechnol 18 380 388
16. S Goh L Good 2008 Plasmid selection in Escherichia coli using an endogenous essential gene marker BMC Biotechnol 8 61
17. JJ Green GT Zugates NC Tedford YH Huang LG Griffith DA Lauffenburger JA Sawicki R Langer DG Anderson 2007 Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus Adv Mater 19 2836 2842
18. P Hägg JW de Pohl F Abdulkarim LA Isaksson 2004 A host/plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli J Biotechnol 111 17 30
19. T Hanke AJ McMichael 2000 Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya Nat Med 6 951 955
20. Hodgson CP, Williams JA (2006) Improved strains of E. coli for plasmid DNA production. WO 2006/026125 A2
21. NA Horn JA Meek G Budahazi M Marquet 1995 Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials Hum Gene Ther 6 565 573
22. MA Kutzler DB. Weiner 2008 DNA vaccines: ready for prime time? Nat Rev Genet 9 776 788
23. J Mairhofer R Grabherr 2008 Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA Mol Biotechnol 39 97 104
24. J Mairhofer I Pfaffenzeller D Merz R Grabherr 2008 A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy Biotechnol J 3 83 89
25. P Mayrhofer M Blaesen M Schleef W Jechlinger 2008 Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography J Gene Med 10 1253 1269
26. JP Moore PJ Klasse MJ Dolan SK Ahuja 2008 AIDS/HIV. A STEP into darkness or light? Science 320 753 755
27. nd edn. ASM Press, Washington D.C. Available via EcoSal. http://www.ecosal.org/ ecosal/chapters/index.jsp?005. Accessed 20 Jan 2009
28. TM vaccine therapy in advanced non-small cell lung cancer (NSCLC) following front-line chemotherapy (STOP). In: ClinicalTrials.gov. U.S. National Library of Medicine. http://clinicaltrials.gov/ct2/show/NCT00676507. Accessed 12 Dec 2008
29. RD O'Kennedy C Baldwin E Keshavarz-Moore 2000 Effects of growth medium selection on plasmid DNA production and initial processing steps J Biotechnol 76 175 183
30. J Okonkowski L Kizer-Bentley K Listner D Robinson M Chartrain 2005 Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine Biotechnol Prog 21 1038 1047
31. PH Oliveira F Lemos GA Monteiro DM Prazeres 2008 Recombination frequency in plasmid DNA containing direct repeats-predictive correlation with repeat and intervening sequence length Plasmid 60 159 165
32. DS Ow PM Nissom R Philp SK Oh MG Yap 2006 Global transcriptional analysis of metabolic burden due to plasmid maintenance in Escherichia coli DH5α during batch fermentation Enzyme Microb Technol 39 391 398
33. DS Ow RM Lee PM Nissom R Philp SK Oh MG Yap 2007 Inactivating FruR global regulator in plasmid-bearing Escherichia coli alters metabolic gene expression and improves growth rate J Biotechnol 131 261 269
34. DS Ow MG Yap SK Oh 2009 Enhancement of plasmid DNA yields during fed-batch culture with a fruR-knockout Escherichia coli strain Biotechnol Appl Biochem 52 53 59
35. CH Pan GS Jimenez N Nair Q Wei RJ Adams FP Polack A Rolland A Vilalta DE Griffin 2008 Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus Clin Vaccine Immunol 15 1214 1221
36. JN Phue SB Noronha R Hattacharyya AJ Wolfe J Shiloach 2005 Glucose metabolism at high density growth of E. coli B and E. coli K: differences in metabolic pathways are responsible for efficient glucose utilization in E. coli B as determined by microarrays and Northern blot analyses Biotechnol Bioeng 90 805 820
37. JN Phue SJ Lee L Trinh J Shiloach 2008 Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha) Biotechnol Bioeng 101 831 836
38. J Pogliano 2002 Dynamic cellular location of bacterial plasmids Curr Opin Microbiol 5 586 590
39. G Posfai G Plunkett III T Feher D Frisch GM Keil K Umenhoffer V Kolisnychenko B Stahl SS Sharma M de Arruda V Burland SW Harcum FR Blattner 2006 Emergent properties of reduced-genome Escherichia coli Science 312 1044 1046
40. KL Prather MC Edmonds JW Herod 2006 Identification and characterization of IS1 transposition in plasmid amplification mutants of E. coli clones producing DNA vaccines Appl Microbiol Biotechnol 73 815 826
41. DMF Prazeres GNM Ferreira 2004 Design of flowsheets for the recovery and purification of plasmids for gene therapy and DNA vaccination Chem Eng Process 43 609 624
42. SC Ribeiro PH Oliveira DM Prazeres GA Monteiro 2008 High frequency plasmid recombination mediated by 28 bp direct repeats Mol Biotechnol 40 252 260
43. Sanofi-Aventis (2008) Efficacy and safety of XRP0038/NV1FGF in critical limb ischemia patients with skin lesions (TAMARIS). In: ClinicalTrials.gov. U.S. National Library of Medicine. http://clinicaltrials.gov/ct2/show/NCT00566657. Accessed 12 Dec 2008
44. D Schneider E Duperchy J Depeyrot E Coursange R Lenski M Blot 2002 Genomic comparisons among Escherichia coli strains B, K-12, and O157:H7 using IS elements as molecular markers BMC Microbiol 2 18
45. F Soubrier B Cameron B Manse S Somarriba C Dubertret G Jaslin G Jung CL Caer D Dang JM Mouvault D Scherman JF Mayaux J Crouzet 1999 pCOR: a new design of plasmid vectors for nonviral gene therapy Gene Ther 6 1482 1488
46. F Soubrier B Laborderie B Cameron 2005 Improvement of pCOR plasmid copy number for pharmaceutical applications Appl Microbiol Biotechnol 66 683 688
47. D Summers 1998 Timing, self-control and a sense of direction are the secrets of multicopy plasmid stability Mol Microbiol 29 1137 1145
48. CY Szpirer MC Milinkovitch 2005 Separate-component-stabilization system for protein and DNA production without the use of antibiotics BioTechniques 38 775 781
49. O Tolmachov I Palaszewski B Bigger C Coutelle 2006 RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia coli strain for Cre mediated production of minicircle DNA BMC Biotechnol 6 17
50. E Twiss AM Coros NP Tavakoli KM Derbyshire 2005 Transposition is modulated by a diverse set of host factors in Escherichia coli and is stimulated by nutritional stress Mol Microbiol 57 1593 1607
51. Vical (2008) A Phase 3 pivotal trial comparing Allovectin-7® alone vs. chemotherapy alone in patients with stage 3 or stage 4 melanoma. In: ClinicalTrials.gov. U.S. National Library of Medicine. http://clinicaltrials. gov/ct2/show/NCT00395070. Accessed 12 Dec 2008
52. L Vidal J Pinsach G Striedner G Caminal P Ferrer 2008 Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli J Biotechnol 134 127 136
53. Z Wang G Le Y Shi G Wegrzyn 2001 Medium design for plasmid DNA production based on stoichiometric model Process Biochem 36 1085 1093
54. SY Yau E Keshavarz-Moore J Ward 2008 Host strain influences on supercoiled plasmid DNA production in Escherichia coli: Implications for efficient design of large-scale processes Biotechnol Bioeng 101 529 544
55. JB Zhao DZ Wei WY Tong 2007 Identification of Escherichia coli host cell for high plasmid stability and improved production of antihuman ovarian carcinoma x antihuman CD3 single-chain bispecific antibody Appl Microbiol Biotechnol 76 795 800
56. U Zielenkiewicz P Ceglowski 2001 Mechanisms of plasmid stable maintenance with special focus on plasmid addiction systems Acta Biochim Pol 48 1003 1023